[Usefulness of intracoronary therapy with progenitor cells in patients with dilated cardiomyopathy: Bridge or alternative to heart transplantation?].

MLA

Rivas, J., et al. “[Usefulness of Intracoronary Therapy with Progenitor Cells in Patients with Dilated Cardiomyopathy: Bridge or Alternative to Heart Transplantation?].” Anales de Pediatria (Barcelona, Spain : 2003), vol. 74, no. 4, Apr. 2011, pp. 218–25. EBSCOhost, https://doi.org/10.1016/j.anpedi.2011.02.013.

APA

Rivas, J., Menéndez, J. J., Arrieta, R., Alves, J., Romero, M. P., García-Guereta, L., Álvarez-Doforno, R., Parrón, M., González, A., Ruza, F., & Gutiérrez-Larraya, F. (2011). [Usefulness of intracoronary therapy with progenitor cells in patients with dilated cardiomyopathy: Bridge or alternative to heart transplantation?]. Anales de Pediatria (Barcelona, Spain : 2003), 74(4), 218–225. https://doi.org/10.1016/j.anpedi.2011.02.013

Chicago

Rivas, J, J J Menéndez, R Arrieta, J Alves, M P Romero, L García-Guereta, R Álvarez-Doforno, et al. 2011. “[Usefulness of Intracoronary Therapy with Progenitor Cells in Patients with Dilated Cardiomyopathy: Bridge or Alternative to Heart Transplantation?].” Anales de Pediatria (Barcelona, Spain : 2003) 74 (4): 218–25. doi:10.1016/j.anpedi.2011.02.013.